Marshall Islands vs Qatar: Prevalence rate of obesity in adults
Marshall Islands
42.0%
in 2024
Qatar
42.0%
in 2024
Marshall Islands rank
18th
Qatar rank
17th
Prevalence rate of obesity in adults over time
- Marshall Islands
- Qatar
How they compare
Qatar currently reports 42.0% against 42.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 1 time across 45 shared years of data; in 1980 it was Marshall Islands ahead.
Marshall Islands ranks 18th and Qatar ranks 17th of 199 countries.
Marshall Islands has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Marshall Islands | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 30.4% | 15.4% | 15.0% | Marshall Islands |
| 1990s | 35.4% | 21.7% | 13.7% | Marshall Islands |
| 2000s | 38.6% | 29.8% | 8.8% | Marshall Islands |
| 2010s | 40.7% | 37.5% | 3.2% | Marshall Islands |
| 2020s | 41.7% | 41.4% | 0.3% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Marshall Islands or Qatar?
- Qatar, at 42.0% against 42.0% in Marshall Islands as of 2024.
- What is the difference in prevalence rate of obesity in adults between Marshall Islands and Qatar?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Marshall Islands and Qatar?
- 45 years are reported by both, from 1980 to 2024.
- How do Marshall Islands and Qatar rank globally for prevalence rate of obesity in adults?
- Marshall Islands ranks 18th and Qatar ranks 17th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.